Pain Medicine, Interventional Pain Medicine · Covington, LA
NPI
1467619254
Since 2008
Specialty
Pain Medicine, Interventional Pain Medicine
Code 208VP0014X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
141 Lakeview Cir
Covington, LA, 70433
Phone (985) 231-6751
Groups this clinician bills Medicare through
Medicare paid, 2024
$255K
4,204 services
Medicare patients, 2024
490
Average age 70
Drug cost, 2024
$1.1M
18,668 prescriptions
Company payments, 2025
$616
From 5 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Ronald C Segura was code 99213 (office e&m - established), 868 times for 313 patients. In total Ronald C Segura billed 4,204 services in 64 codes, and Medicare paid $255K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-04-12.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 868 | 313 | $63.96 | $56K |
| 99214 Office E&M - Established | Office | 805 | 366 | $89.99 | $72K |
| 80305 Drug Tests | Office | 608 | 293 | $12.33 | $7,498 |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 370 | 29 | $0.07 | $27.67 |
| J1885 Injection, ketorolac tromethamine, per 15 mg | Office | 124 | 30 | $0.47 | $58.3 |
| 76942 Ultrasound - Nonspecific | Office | 117 | 28 | $43.19 | $5,053 |
| 62370 Musculoskeletal | Office | 113 | 23 | $67.04 | $7,575 |
| 99204 Office E&M - New | Office | 112 | 112 | $123.27 | $14K |
| 64483 Nerve Block Injection - Back | Facility | 95 | 66 | $89.06 | $8,460 |
| 64484 Nerve Block Injection - Back | Facility | 81 | 59 | $41.82 | $3,387 |
| 64493 Nerve Block Injection - Back | Facility | 79 | 47 | $90.60 | $7,157 |
| 64494 Nerve Block Injection - Back | Facility | 73 | 43 | $51.84 | $3,784 |
| 64635 Destruction by Neurolytic Agent - Back | Facility | 72 | 51 | $144.05 | $10K |
| 64636 Destruction by Neurolytic Agent - Back | Facility | 70 | 48 | $44.06 | $3,084 |
| 64490 Nerve Block Injection - Back | Facility | 65 | 31 | $109.24 | $7,101 |
By year: 2022 $252K for 4,456 services; 2023 $228K for 4,322 services; 2024 $255K for 4,204 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 80305 Drug Tests | 608 | 293 | $12.33 | $7,498 |
Medicare prescription drug claims, 2024
In 2024, the drug Ronald C Segura prescribed most often to Medicare patients was Oxycodone Hcl, with 3,438 prescriptions and refills. In total Ronald C Segura wrote 18,668 Medicare prescriptions that cost $1.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Oxycodone Hcl Generic | 3,438 | 3,438 | 396 | $86K |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 3,403 | 3,403 | 497 | $90K |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 3,087 | 3,095 | 411 | $112K |
| Gabapentin Generic | 2,700 | 3,511 | 471 | $42K |
| Pregabalin Generic | 1,151 | 1,343 | 225 | $17K |
| Morphine Sulfate Er Morphine Sulfate | 1,110 | 1,113 | 128 | $37K |
| Tramadol Hcl Generic | 703 | 710 | 142 | $5,996 |
| Xtampza Er Oxycodone Myristate | 350 | 358 | 47 | $249K |
| Hydromorphone Hcl Generic | 267 | 267 | 39 | $4,511 |
| Butalbital-Acetaminophen-Caffe Butalb/Acetaminophen/Caffeine | 206 | 232 | 38 | $9,154 |
| Oxycontin Oxycodone Hcl | 181 | 181 | 26 | $117K |
| Carisoprodol Generic | 171 | 171 | 28 | $1,278 |
| Tizanidine Hcl Generic | 168 | 200 | 78 | $1,571 |
| Buprenorphine Generic | 146 | 146 | 28 | $44K |
| Fentanyl Generic | 137 | 137 | 22 | $23K |
Brand drugs: 846 claims; generic drugs: 17,822 claims; opioid claims: 13,185.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Ronald C Segura $616 ($616 in general payments such as food, travel and fees) from 5 companies. The largest payer was BIOTRONIK NRO, Inc. with $404.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.